Results 181 to 190 of about 105,160 (358)
Analysis of Treatment and Subsequent Pregnancy Outcomes in Patients With Antinuclear Antibody-Positive Recurrent Spontaneous Abortion. [PDF]
Wang A+5 more
europepmc +1 more source
Yellow fever vaccination and risk of spontaneous abortion [PDF]
Frank Cobelens
openalex +1 more source
Induced Abortion After Previous Caesarean Section: A Scoping Review
ABSTRACT Background Previous caesarean section (CS) is increasingly common among women undergoing induced abortion. Aims To map and analyse existing literature on abortion safety, outcomes and management in those with previous CS. Materials and Methods Four databases were systematically searched from inception to July 2024.
Natalie Drever+6 more
wiley +1 more source
Abstract Background Growing evidence indicates that paternal condition significantly influences pregnancy outcomes and offspring health. However, assessing the safety of paternal drug exposure via randomized controlled trials poses ethical challenges, and relevant clinical studies consume a lot of resources to evaluate only a few drugs.
Yanbin Zeng, Wanlong Lin, Wei Zhuang
wiley +1 more source
A nomogram based on hematological parameters for prediction of spontaneous abortion risk in pregnancies. [PDF]
Xiang J, Liu L, Bao R, Cai Z.
europepmc +1 more source
Are spontaneous abortion rates useful in monitoring reproductive hazards? [PDF]
Fabio Parazzini+2 more
openalex +1 more source
Abstract Aim The aim was to investigate the association between night work during pregnancy and the risk of having a male offspring with cryptorchidism. Furthermore, we explored if the risk of cryptorchidism increased based on trimester‐specific night work (gestational weeks 1–12 and 13–22) by sensitivity analyses.
Charlotte Bertelsen+8 more
wiley +1 more source
Research trends and hotspots of recurrent spontaneous abortion with immune dysfunction: A bibliometric analysis from 2004 to 2024. [PDF]
Shi Y+5 more
europepmc +1 more source
Progesterone treatment initiated before 22 gestational weeks in mothers with a short cervix may prevent preterm birth before 28 and possibly 34 weeks. No benefit is observed when treatment begins after 28 weeks or for preterm birth before 37 weeks. Abstract Introduction Randomized trials have shown that progesterone treatment in mothers with a short ...
Anders Einum+4 more
wiley +1 more source